Phibro Animal Health Corporation (PAHC)
PAHC Stock Price Chart
Explore Phibro Animal Health Corporation interactive price chart. Choose custom timeframes to analyze PAHC price movements and trends.
PAHC Company Profile
Discover essential business fundamentals and corporate details for Phibro Animal Health Corporation (PAHC) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
11 Apr 2014
Employees
1.94K
Website
https://www.pahc.comCEO
Jack Clifford Bendheim
Description
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It operates in the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 2014 and is headquartered in Teaneck, New Jersey.
PAHC Financial Timeline
Browse a chronological timeline of Phibro Animal Health Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 May 2026
Upcoming earnings on 3 Feb 2026
Upcoming earnings on 5 Nov 2025
EPS estimate is $0.51, while revenue estimate is $345.44M.
Earnings released on 27 Aug 2025
EPS came in at $0.57 surpassing the estimated $0.52 by +9.62%, while revenue for the quarter reached $378.70M , beating expectations by +4.50%.
Dividend declared on 29 Jul 2025
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend will be paid on 24 Sept 2025.
Earnings released on 7 May 2025
EPS came in at $0.63 surpassing the estimated $0.52 by +21.15%, while revenue for the quarter reached $347.83M , missing expectations by -3.98%.
Dividend declared on 6 May 2025
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 25 Jun 2025.
Earnings released on 5 Feb 2025
EPS came in at $0.54 surpassing the estimated $0.40 by +35.00%, while revenue for the quarter reached $309.26M , missing expectations by -10.88%.
Dividend declared on 4 Feb 2025
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 26 Mar 2025.
Earnings released on 7 Nov 2024
EPS came in at $0.35 surpassing the estimated $0.25 by +40.00%, while revenue for the quarter reached $260.43M , beating expectations by +6.56%.
Dividend declared on 5 Nov 2024
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 18 Dec 2024.
Earnings released on 28 Aug 2024
EPS came in at $0.41 surpassing the estimated $0.34 by +20.59%, while revenue for the quarter reached $273.16M , beating expectations by +3.77%.
Dividend declared on 30 Jul 2024
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 25 Sept 2024.
Earnings released on 8 May 2024
EPS came in at $0.31 surpassing the estimated $0.29 by +6.90%, while revenue for the quarter reached $263.22M , missing expectations by -0.01%.
Dividend declared on 7 May 2024
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 26 Jun 2024.
Earnings released on 7 Feb 2024
EPS came in at $0.33 surpassing the estimated $0.27 by +22.22%, while revenue for the quarter reached $249.94M , missing expectations by -0.54%.
Dividend declared on 6 Feb 2024
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 27 Mar 2024.
Earnings released on 8 Nov 2023
EPS came in at $0.14 falling short of the estimated $0.21 by -33.33%, while revenue for the quarter reached $231.30M , missing expectations by -4.44%.
Dividend declared on 6 Nov 2023
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 20 Dec 2023.
Earnings released on 30 Aug 2023
EPS came in at $0.38 falling short of the estimated $0.40 by -5.00%, while revenue for the quarter reached $255.05M , beating expectations by +7.02%.
Dividend declared on 25 Jul 2023
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 27 Sept 2023.
Earnings released on 3 May 2023
EPS came in at $0.29 falling short of the estimated $0.34 by -14.71%, while revenue for the quarter reached $245.67M , missing expectations by -4.98%.
Dividend declared on 1 May 2023
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 28 Jun 2023.
Earnings released on 8 Feb 2023
EPS came in at $0.34 surpassing the estimated $0.30 by +13.33%, while revenue for the quarter reached $244.65M , beating expectations by +1.39%.
Dividend declared on 6 Feb 2023
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 22 Mar 2023.
Earnings released on 9 Nov 2022
EPS came in at $0.21 falling short of the estimated $0.26 by -19.23%, while revenue for the quarter reached $232.52M , beating expectations by +0.18%.
Dividend declared on 7 Nov 2022
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 21 Dec 2022.
Earnings released on 24 Aug 2022
EPS came in at $0.36 falling short of the estimated $0.40 by -10.00%, while revenue for the quarter reached $255.30M , beating expectations by +2.10%.
Dividend declared on 25 Jul 2022
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 28 Sept 2022.
Earnings released on 4 May 2022
EPS came in at $0.33 falling short of the estimated $0.35 by -5.71%, while revenue for the quarter reached $239.62M , beating expectations by +3.94%.
Dividend declared on 2 May 2022
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 22 Jun 2022.
Earnings released on 9 Feb 2022
EPS came in at $0.37 surpassing the estimated $0.33 by +12.12%, while revenue for the quarter reached $232.71M , beating expectations by +8.10%.
Dividend declared on 7 Feb 2022
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 23 Mar 2022.
Earnings released on 2 Nov 2021
EPS came in at $0.25 falling short of the estimated $0.28 by -10.71%, while revenue for the quarter reached $214.67M , beating expectations by +6.15%.
Dividend declared on 1 Nov 2021
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 15 Dec 2021.
Earnings released on 25 Aug 2021
EPS came in at $0.32 surpassing the estimated $0.31 by +3.23%, while revenue for the quarter reached $220.30M , beating expectations by +8.94%.
Dividend declared on 26 Jul 2021
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 22 Sept 2021.
Earnings released on 6 May 2021
EPS came in at $0.34 matching the estimated $0.34, while revenue for the quarter reached $211.73M , beating expectations by +1.76%.
Dividend declared on 3 May 2021
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 23 Jun 2021.
Earnings released on 3 Feb 2021
EPS came in at $0.34 surpassing the estimated $0.27 by +25.93%, while revenue for the quarter reached $206.15M , beating expectations by +35.00%.
Dividend declared on 1 Feb 2021
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 24 Mar 2021.
Earnings released on 4 Nov 2020
EPS came in at $0.27 surpassing the estimated $0.23 by +17.39%, while revenue for the quarter reached $195.19M , beating expectations by +17.39%.
Dividend declared on 2 Nov 2020
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 16 Dec 2020.
PAHC Stock Performance
Access detailed PAHC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.